4//SEC Filing
Campbell Shane Alden 4
Accession 0001127602-25-014250
CIK 0000105770other
Filed
May 13, 8:00 PM ET
Accepted
May 14, 4:04 PM ET
Size
12.3 KB
Accession
0001127602-25-014250
Insider Transaction Report
Form 4
Campbell Shane Alden
SVP, Proprietary Segment
Transactions
- Award
Stock Options (Right to Buy)
2025-05-12$219.46/sh+2,852$625,900→ 2,852 totalExercise: $219.46From: 2026-05-12Exp: 2035-05-12→ Stock Options (Right to Buy) (2,852 underlying) - Award
Rst. Stock Unit
2025-05-12+1,182→ 1,182 totalExercise: $0.00→ Common Stock (1,182 underlying) - Award
Rst. Stock Unit
2025-05-12+1,891→ 1,891 totalExercise: $0.00→ Common Stock (1,891 underlying)
Footnotes (1)
- [F1]This award vests in four equal annual installments beginning on May 12, 2026.
Issuer
WEST PHARMACEUTICAL SERVICES INC
CIK 0000105770
Entity typeother
Related Parties
1- filerCIK 0002068522
Filing Metadata
- Form type
- 4
- Filed
- May 13, 8:00 PM ET
- Accepted
- May 14, 4:04 PM ET
- Size
- 12.3 KB